The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1)
- 31 December 1993
- journal article
- Published by Elsevier in Life Sciences
- Vol. 53 (24), PL399-PL403
- https://doi.org/10.1016/0024-3205(93)90495-o
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- P-glycoprotein-mediated renal tubular secretion of digoxin: The toxicological significance of the urine-blood barrier modelLife Sciences, 1993
- Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1)Canadian Journal of Physiology and Pharmacology, 1993
- The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxinBiochemical and Biophysical Research Communications, 1992
- Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heartBritish Journal of Pharmacology, 1985
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985
- The influence of verapamil on serum digoxin concentration.Circulation, 1982
- The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjectsEuropean Journal of Clinical Pharmacology, 1982
- Digoxin-verapamil interactionClinical Pharmacology & Therapeutics, 1981